The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jingyu Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier]
卷期号:115: 154847-154847 被引量:1
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
飞天817完成签到,获得积分10
1秒前
小马哥完成签到,获得积分10
1秒前
1秒前
超级萌琦完成签到,获得积分10
1秒前
爆米花应助牛牛采纳,获得10
1秒前
星辰大海应助人间枝头采纳,获得10
1秒前
丘比特应助牧瞻采纳,获得10
2秒前
小赵同学完成签到,获得积分10
2秒前
群山完成签到 ,获得积分10
3秒前
CipherSage应助liz采纳,获得10
3秒前
DreamMaker完成签到,获得积分10
4秒前
无花果应助冷酷的雅寒采纳,获得10
4秒前
luojun发布了新的文献求助10
5秒前
Hello应助YBY采纳,获得10
6秒前
6秒前
素直发布了新的文献求助10
6秒前
小蘑菇应助汕头凯奇采纳,获得10
7秒前
WAKAKA完成签到,获得积分10
7秒前
苑lanjie完成签到,获得积分10
7秒前
研友_VZG7GZ应助小赵同学采纳,获得10
8秒前
8秒前
努力发NAT完成签到,获得积分10
8秒前
幽默元容发布了新的文献求助10
9秒前
KK发布了新的文献求助10
9秒前
我是老大应助咕咕鸡采纳,获得10
10秒前
11秒前
拓跋叡完成签到,获得积分0
11秒前
易琚完成签到,获得积分10
11秒前
爆米花应助素直采纳,获得10
12秒前
远山发布了新的文献求助10
12秒前
充电宝应助人间枝头采纳,获得10
12秒前
SciGPT应助木子采纳,获得10
13秒前
14秒前
曹显旻完成签到,获得积分10
14秒前
乐乐应助乐观的访风采纳,获得80
15秒前
充电宝应助廖程采纳,获得10
15秒前
0729发布了新的文献求助80
16秒前
16秒前
高分求助中
Lire en communiste 1000
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 800
Becoming: An Introduction to Jung's Concept of Individuation 600
中国氢能技术发展路线图研究 500
Communist propaganda: a fact book, 1957-1958 500
Briefe aus Shanghai 1946‒1952 (Dokumente eines Kulturschocks) 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3169302
求助须知:如何正确求助?哪些是违规求助? 2820519
关于积分的说明 7931311
捐赠科研通 2480910
什么是DOI,文献DOI怎么找? 1321571
科研通“疑难数据库(出版商)”最低求助积分说明 633287
版权声明 602528